These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1165 related articles for article (PubMed ID: 12376810)

  • 1. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous venovenous hemofiltration with citrate-based replacement fluid: efficacy, safety, and impact on nutrition.
    Bihorac A; Ross EA
    Am J Kidney Dis; 2005 Nov; 46(5):908-18. PubMed ID: 16253732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regional citrate anticoagulation in predilution continuous venovenous hemofiltration using prismocitrate 10/2 solution.
    Shum HP; Chan KC; Yan WW
    Ther Apher Dial; 2012 Feb; 16(1):81-6. PubMed ID: 22248200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients.
    Thoenen M; Schmid ER; Binswanger U; Schuepbach R; Aerne D; Schmidlin D
    Wien Klin Wochenschr; 2002 Feb; 114(3):108-14. PubMed ID: 12060967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is regional citrate superior to systemic heparin anticoagulation for continuous renal replacement therapy? A prospective observational study in an adult regional critical care system.
    Bagshaw SM; Laupland KB; Boiteau PJ; Godinez-Luna T
    J Crit Care; 2005 Jun; 20(2):155-61. PubMed ID: 16139156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions.
    Cointault O; Kamar N; Bories P; Lavayssiere L; Angles O; Rostaing L; Genestal M; Durand D
    Nephrol Dial Transplant; 2004 Jan; 19(1):171-8. PubMed ID: 14671053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A continuous veno-venous hemofiltration protocol with anticoagulant citrate dextrose formula A and a calcium-containing replacement fluid.
    Ong SC; Wille KM; Speer R; Tolwani AJ
    Int J Artif Organs; 2014 Jun; 37(6):499-502. PubMed ID: 24811309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional citrate anticoagulation for PrismaFlex continuous renal replacement therapy.
    Burry LD; Tung DD; Hallett D; Bailie T; Carvalhana V; Lee D; Ramganesh S; Richardson R; Mehta S; Lapinsky SE
    Ann Pharmacother; 2009 Sep; 43(9):1419-25. PubMed ID: 19690224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate.
    Gupta M; Wadhwa NK; Bukovsky R
    Am J Kidney Dis; 2004 Jan; 43(1):67-73. PubMed ID: 14712429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy.
    Nagarik AP; Soni SS; Adikey GK; Raman A
    Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate kinetics in patients receiving long-term hemodialysis therapy.
    Bauer E; Derfler K; Joukhadar C; Druml W
    Am J Kidney Dis; 2005 Nov; 46(5):903-7. PubMed ID: 16253731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status.
    Morgera S; Schneider M; Slowinski T; Vargas-Hein O; Zuckermann-Becker H; Peters H; Kindgen-Milles D; Neumayer HH
    Crit Care Med; 2009 Jun; 37(6):2018-24. PubMed ID: 19384210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding.
    Palsson R; Niles JL
    Kidney Int; 1999 May; 55(5):1991-7. PubMed ID: 10231464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving the delivery of continuous renal replacement therapy using regional citrate anticoagulation.
    Swartz R; Pasko D; O'Toole J; Starmann B
    Clin Nephrol; 2004 Feb; 61(2):134-43. PubMed ID: 14989634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration.
    DelDot ME; Lipman J; Tett SE
    Br J Clin Pharmacol; 2004 Sep; 58(3):259-68. PubMed ID: 15327585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citrate anticoagulation in pediatric continuous venovenous hemofiltration.
    Elhanan N; Skippen P; Nuthall G; Krahn G; Seear M
    Pediatr Nephrol; 2004 Feb; 19(2):208-12. PubMed ID: 14669096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT).
    Brophy PD; Somers MJ; Baum MA; Symons JM; McAfee N; Fortenberry JD; Rogers K; Barnett J; Blowey D; Baker C; Bunchman TE; Goldstein SL
    Nephrol Dial Transplant; 2005 Jul; 20(7):1416-21. PubMed ID: 15855212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional citrate anticoagulation reduces polymorphonuclear cell degranulation in critically ill patients treated with continuous venovenous hemofiltration.
    Tiranathanagul K; Jearnsujitwimol O; Susantitaphong P; Kijkriengkraikul N; Leelahavanichkul A; Srisawat N; Praditpornsilpa K; Eiam-Ong S
    Ther Apher Dial; 2011 Dec; 15(6):556-64. PubMed ID: 22107692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.